Skip to main content
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2002 Mar;72(Suppl 1):i22–i27. doi: 10.1136/jnnp.72.suppl_1.i22

MEDICAL MANAGEMENT OF PARKINSON'S DISEASE

C Clarke
PMCID: PMC1765581  PMID: 11870200

Full Text

The Full Text of this article is available as a PDF (161.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ben-Shlomo Y., Churchyard A., Head J., Hurwitz B., Overstall P., Ockelford J., Lees A. J. Investigation by Parkinson's Disease Research Group of United Kingdom into excess mortality seen with combined levodopa and selegiline treatment in patients with early, mild Parkinson's disease: further results of randomised trial and confidential inquiry. BMJ. 1998 Apr 18;316(7139):1191–1196. doi: 10.1136/bmj.316.7139.1191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bhatia K., Brooks D. J., Burn D. J., Clarke C. E., Playfer J., Sawle G. V., Schapira A. H., Stewart D., Williams A. C. Guidelines for the management of Parkinson's disease. The Parkinson's Disease Consensus Working Group. Hosp Med. 1998 Jun;59(6):469–480. [PubMed] [Google Scholar]
  3. Clarke C. E. Does levodopa therapy delay death in Parkinson's disease? A review of the evidence. Mov Disord. 1995 May;10(3):250–256. doi: 10.1002/mds.870100303. [DOI] [PubMed] [Google Scholar]
  4. Frankel J. P., Lees A. J., Kempster P. A., Stern G. M. Subcutaneous apomorphine in the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry. 1990 Feb;53(2):96–101. doi: 10.1136/jnnp.53.2.96. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Olanow C. W., Watts R. L., Koller W. C. An algorithm (decision tree) for the management of Parkinson's disease (2001): treatment guidelines. Neurology. 2001 Jun;56(11 Suppl 5):S1–S88. doi: 10.1212/wnl.56.suppl_5.s1. [DOI] [PubMed] [Google Scholar]
  6. Rascol O., Brooks D. J., Korczyn A. D., De Deyn P. P., Clarke C. E., Lang A. E. A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. N Engl J Med. 2000 May 18;342(20):1484–1491. doi: 10.1056/NEJM200005183422004. [DOI] [PubMed] [Google Scholar]
  7. Schapira A. H. Science, medicine, and the future: Parkinson's disease. BMJ. 1999 Jan 30;318(7179):311–314. doi: 10.1136/bmj.318.7179.311. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES